Crown Advisors Management’s Bio-Techne TECH Stock Holding History

Crown Advisors Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-24,000	Closed	-$2.6M	–	51
2022 Q1	$2.6M	Hold	24,000	–	–	1.83%	26
2021 Q4	$3.1M	Hold	24,000	–	–	2%	22
2021 Q3	$2.91M	Hold	24,000	–	–	2.04%	23
2021 Q2	$2.7M	Hold	24,000	–	–	1.87%	24
2021 Q1	$2.29M	Sell	24,000 -8,000	-25%	-$730K	1.8%	25
2020 Q4	$2.54M	Hold	32,000	–	–	1.82%	31
2020 Q3	$1.98M	Sell	32,000 -28,000	-47%	-$1.82M	1.29%	37
2020 Q2	$3.96M	Hold	60,000	–	–	2.71%	17
2020 Q1	$2.84M	Sell	60,000 -8,000	-12%	-$400K	2.25%	28
2019 Q4	$3.73M	Hold	68,000	–	–	2.4%	18
2019 Q3	$3.33M	Buy	+68,000	New	+$3.41M	2.23%	18

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Crown Advisors Management's TECH Position: Q2 2022 in Review

Crown Advisors Management sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 24,000 shares — an estimated $2.6M sold.

Crown Advisors Management first reported a position in TECH in Q3 2019 and held it in 11 quarters. The position peaked at $3.96M in Q2 2020. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

Crown Advisors Management reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
Crown Advisors Management sold 24,000 Bio-Techne shares in Q2 2022, an estimated $2.6M.
Crown Advisors Management first reported a position in Bio-Techne in Q3 2019 and held it in 11 quarters.
Crown Advisors Management's Bio-Techne position peaked at $3.96M in Q2 2020.
550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Crown Advisors Management's 13F filing for Q2 2022, filed 11 Aug 2022.